Nicolas Picard

4.1k total citations
81 papers, 2.5k citations indexed

About

Nicolas Picard is a scholar working on Transplantation, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nicolas Picard has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Transplantation, 20 papers in Molecular Biology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nicolas Picard's work include Renal Transplantation Outcomes and Treatments (32 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Nicolas Picard is often cited by papers focused on Renal Transplantation Outcomes and Treatments (32 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Nicolas Picard collaborates with scholars based in France, United States and Chile. Nicolas Picard's co-authors include Pierre Marquet, Yannick Le Meur, Jean‐Baptiste Woillard, Aurélie Prémaud, François‐Ludovic Sauvage, Nassim Djebli, Marie‐Laure Laroche, Yves Nouaille, Damrong Ratanasavanh and Jean‐Pierre Charmes and has published in prestigious journals such as Analytical Biochemistry, Clinical Chemistry and Life Sciences.

In The Last Decade

Nicolas Picard

76 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Picard France 29 968 697 502 489 425 81 2.5k
Jung Mi Oh South Korea 24 458 0.5× 379 0.5× 293 0.6× 204 0.4× 182 0.4× 139 1.7k
Raymond G. Morris Australia 24 729 0.8× 666 1.0× 230 0.5× 285 0.6× 170 0.4× 92 1.8k
Zheng Jiao China 27 491 0.5× 663 1.0× 239 0.5× 274 0.6× 267 0.6× 109 1.9k
Peter I. Pillans Australia 29 597 0.6× 329 0.5× 236 0.5× 95 0.2× 128 0.3× 93 2.2k
Christine Fernandez France 29 147 0.2× 431 0.6× 394 0.8× 498 1.0× 168 0.4× 104 2.2k
Flora T. Musuamba Belgium 22 328 0.3× 295 0.4× 232 0.5× 192 0.4× 229 0.5× 48 1.8k
Dario Cattaneo Italy 38 1.7k 1.7× 795 1.1× 747 1.5× 437 0.9× 230 0.5× 233 5.8k
Frieder Keller Germany 29 208 0.2× 294 0.4× 333 0.7× 246 0.5× 140 0.3× 160 2.8k
Mingkang Zhong China 25 231 0.2× 291 0.4× 448 0.9× 258 0.5× 235 0.6× 100 1.7k
Brenda C. M. de Winter Netherlands 29 1.1k 1.1× 669 1.0× 160 0.3× 142 0.3× 114 0.3× 130 2.2k

Countries citing papers authored by Nicolas Picard

Since Specialization
Citations

This map shows the geographic impact of Nicolas Picard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Picard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Picard more than expected).

Fields of papers citing papers by Nicolas Picard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Picard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Picard. The network helps show where Nicolas Picard may publish in the future.

Co-authorship network of co-authors of Nicolas Picard

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Picard. A scholar is included among the top collaborators of Nicolas Picard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Picard. Nicolas Picard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Picard, Nicolas, et al.. (2024). Tramadol intoxication in children: An emerging issue. Therapies. 79(6). 670–674. 1 indexed citations
3.
Hãhn, Oliver, et al.. (2024). Interest and limits of using pharmacogenetics in MDMA-related fatalities: A case report. Forensic Science International Genetics. 76. 103219–103219. 1 indexed citations
4.
Clérandeau, Christelle, Nicolas Picard, Warren Albertin, et al.. (2024). Study of intense pulsed light as a new remediation process for pesticides in water using mass spectrometry and ecotoxicological approaches. Journal of Hazardous Materials Advances. 17. 100577–100577.
5.
Blin, Olivier, Arnaud Bayle, Christophe Le Tourneau, et al.. (2023). Comment faire entrer la médecine de précision dans la décision thérapeutique de routine au lit du malade ?. Therapies. 79(1). 1–11.
6.
Blin, Olivier, Arnaud Bayle, Christophe Le Tourneau, et al.. (2023). Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients?. Therapies. 79(1). 13–22. 1 indexed citations
7.
Picard, Nicolas, et al.. (2020). Pitfalls and challenges associated with phenoconversion in forensic toxcicology. Forensic Science International Genetics. 51. 102433–102433. 9 indexed citations
8.
Thomas, Fabienne, Gareth J. Veal, Souleiman El Balkhi, et al.. (2018). Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report. Cancer Chemotherapy and Pharmacology. 82(2). 361–365. 7 indexed citations
9.
Woillard, Jean‐Baptiste, et al.. (2018). A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen. American Journal of Transplantation. 18(12). 2905–2913. 13 indexed citations
10.
Woillard, Jean‐Baptiste, Laurent Chouchana, Nicolas Picard, & Marie‐Anne Loriot. (2017). Pharmacogénétique des immunosuppresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx). Therapies. 72(2). 269–284. 1 indexed citations
11.
Saint‐Marcoux, Franck, Marie Essig, Jean-Philippe Rérolle, et al.. (2016). Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients. Pharmacological Research. 111. 501–508. 20 indexed citations
12.
Étienne-Grimaldi, Marie-Christine, Fabienne Thomas, Sylvie Quaranta, et al.. (2015). UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice. Fundamental and Clinical Pharmacology. 29(3). 219–237. 84 indexed citations
13.
Shipkova, Maria, Nicolas Picard, Ofelia Noceti, et al.. (2015). Analytical Aspects of the Implementation of Biomarkers in Clinical Transplantation. Therapeutic Drug Monitoring. 38(Supplement 1). S80–S92. 4 indexed citations
14.
Woillard, Jean‐Baptiste, Nicolas Picard, Antoine Thierry, Guy Touchard, & Pierre Marquet. (2014). Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients. Pharmacogenetics and Genomics. 24(5). 256–262. 27 indexed citations
15.
Woillard, Jean‐Baptiste, Jean-Philippe Rérolle, Nicolas Picard, et al.. (2010). Risk of diarrhoea in a long‐term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8*2 variant allele. British Journal of Clinical Pharmacology. 69(6). 675–683. 35 indexed citations
16.
Picard, Nicolas, Sook Wah Yee, Jean‐Baptiste Woillard, et al.. (2009). The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics. Clinical Pharmacology & Therapeutics. 87(1). 100–108. 123 indexed citations
17.
Bruston, Francine, C. Lacombe, Klaus Zimmermann, et al.. (2007). Structural malleability of plasticins: Preorganized conformations in solution and relevance for antimicrobial activity. Biopolymers. 86(1). 42–56. 21 indexed citations
18.
Djebli, Nassim, Nicolas Picard, Jean-Philippe Rérolle, Yannick Le Meur, & Pierre Marquet. (2007). Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients. Pharmacogenetics and Genomics. 17(5). 321–330. 66 indexed citations
19.
Laroche, Marie‐Laure, Jean‐Pierre Charmes, Yves Nouaille, Nicolas Picard, & Louis Merle. (2006). Is inappropriate medication use a major cause of adverse drug reactions in the elderly?. British Journal of Clinical Pharmacology. 63(2). 177–186. 232 indexed citations
20.
Picard, Nicolas, et al.. (2004). Characterization of a Phase 1 Metabolite of Mycophenolic Acid Produced by CYP3A4/5. Therapeutic Drug Monitoring. 26(6). 600–608. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026